Telomerase reverse transcriptase acts in a feedback loop with NF-? B pathway to regulate macrophage polarization in alcoholic liver disease

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Wu, Xiao Qin ^a   Yang, Yang ^a   Li, Wan Xia ^a   Cheng, Ya Hui ^a   Li, Xiao Feng ^a   Huang, Cheng ^a   Meng, Xiao Ming ^a   Wu, Bao Ming ^a   Liu, Xin Hua ^a   Zhang, Lei ^a   Lv, Xiong Wen ^a   Li, Jun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; TELOMERASE;

ALCOHOL LIVER DISEASE; ANIMAL; C57BL MOUSE; CELL POLARITY; ENZYMOLOGY; FEEDBACK SYSTEM; GENE EXPRESSION; IMMUNOLOGY; KUPFFER CELL; LIVER; MALE; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; RAW 264.7 CELL LINE; SIGNAL TRANSDUCTION;

ANIMALS; CELL POLARITY; FEEDBACK, PHYSIOLOGICAL; GENE EXPRESSION; KUPFFER CELLS; LIPOPOLYSACCHARIDES; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; MICE; MICE, INBRED C57BL; NF-KAPPA B; RAW 264.7 CELLS; SIGNAL TRANSDUCTION; TELOMERASE;

EID: 84952925002     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18685     Document Type: Article

References (58)

1. Gao, B. & Bataller, R. Alcoholic liver disease: pathogenesis and new therapeutic targets. Gastroenterology 141, 1572-1585 (2011).
2. Rehm, J. et al. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 373, 2223-2233 (2009).
3. Mathurin, P. & Bataller, R. Trends in the management and burden of alcoholic liver disease. J Hepatol 62, S38-S46 (2015).
4. Szabo, G. Gut-liver axis in alcoholic liver disease. Gastroenterology 148, 30-36 (2015).
5. Louvet, A. & Mathurin, P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol 12, 231-242 (2015).
6. Dey, A. & Cederbaum, A. I. Alcohol and oxidative liver injury. Hepatology 43, S63-74 (2006).
7. Nagy, L. E. Molecular aspects of alcohol metabolism: Transcription factors involved in early ethanol-induced liver injury. Annu Rev Nutr 24, 55-78 (2004).
8. Wang, H. J., Gao, B., Zakhari, S. & Nagy, L. E. Inflammation in alcoholic liver disease. Annu Rev Nutr 32, 343-368 (2012).
9. An, L., Wang, X. & Cederbaum, A. I. Cytokines in alcoholic liver disease. Arch Toxicol 86, 1337-1348 (2012).
10. Enomoto, N. et al. Role of Kupffer cells and gut-derived endotoxins in alcoholic liver injury. J Gastroenterol Hepatol 15 Suppl, D20-25 (2000).
11. McClain, C. J., Hill, D. B., Song, Z., Deaciuc, I. & Barve, S. Monocyte activation in alcoholic liver disease. Alcohol 27, 53-61 (2002).
12. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958-969 (2008).
13. Romagnani, P., Annunziato, F., Piccinni, M. P., Maggi, E. & Romagnani, S. Th1/Th2 cells, their associated molecules and role in pathophysiology. Eur Cytokine Netw 11, 510-511 (2000).
14. Gordon, S. Alternative activation of macrophages. Nat Rev Immunol 3, 23-35 (2003).
15. Gordon, S. & Martinez, F. O. Alternative activation of macrophages: mechanism and functions. Immunity 32, 593-604 (2010).
16. Locati, M., Mantovani, A. & Sica, A. Macrophage activation and polarization as an adaptive component of innate immunity. Adv Immunol 120, 163-184 (2013).
17. Murray, P. J. et al. Macrophage activation and polarization: nomenclature and experimental guidelines. Immunity 41, 14-20 (2014).
18. Wynn, T. A., Chawla, A. & Pollard, J. W. Macrophage biology in development, homeostasis and disease. Nature 496, 445-455 (2013).
19. Murray, P. J. & Wynn, T. A. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11, 723-737 (2011).
20. Heymann, F. et al. Liver inflammation abrogates immunological tolerance induced by Kupffer cells. Hepatology 62, 279-291 (2015).
21. Marchetti, V. et al. Differential macrophage polarization promotes tissue remodeling and repair in a model of ischemic retinopathy. Sci Rep 1, 76 (2011).
22. Wan, J., Benkdane, M., Alons, E., Lotersztajn, S. & Pavoine, C. M2 kupffer cells promote hepatocyte senescence: An IL-6-dependent protective mechanism against alcoholic liver disease. Am J Pathol 184, 1763-1772 (2014).
23. Wan, J. et al. M2 Kupffer cells promote M1 Kupffer cell apoptosis: A protective mechanism against alcoholic and nonalcoholic fatty liver disease. Hepatology 59, 130-142 (2014).
24. Sandin, S. & Rhodes, D. Telomerase structure. Curr Opin Struct Biol 25, 104-110 (2014).
25. Schmidt, J. C. & Cech, T. R. Human telomerase: biogenesis, trafficking, recruitment, and activation. Genes Dev 29, 1095-1105 (2015).
26. Heidenreich, B., Rachakonda, P. S., Hemminki, K. & Kumar, R. TERT promoter mutations in cancer development. Curr Opin Genet Dev 24, 30-37 (2014).
27. Ye, J., Renault, V. M., Jamet, K. & Gilson, E. Transcriptional outcome of telomere signalling. Nat Rev Genet 15, 491-503 (2014).
28. Lechel, A., Manns, M. P. & Rudolph, K. L. Telomeres and telomerase: new targets for the treatment of liver cirrhosis and hepatocellular carcinoma. J Hepatol 41, 491-497 (2004).
29. Gizard, F. et al. Telomerase activation in atherosclerosis and induction of telomerase reverse transcriptase expression by inflammatory stimuli in macrophages. Arterioscler Thromb Vasc Biol 31, 245-252 (2011).
30. Szabo, G. & Mandrekar, P. Human monocytes, macrophages, and dendritic cells: Alcohol treatment methods. Methods Mol Biol 447, 113-124 (2008).
31. Oeckinghaus, A., Hayden, M. S. & Ghosh, S. Crosstalk in NF-kappaB signaling pathways. Nat Immunol 12, 695-708 (2011).
32. Oh, H. & Ghosh, S. NF-kappaB: roles and regulation in different CD4(+ ) T-cell subsets. Immunol Rev 252, 41-51 (2013).
33. Yin, L., Hubbard, A. K. & Giardina, C. NF-kappa B regulates transcription of the mouse telomerase catalytic subunit. J Biol Chem 275, 36671-36675 (2000).
34. Harada, K., Yasoshima, M., Ozaki, S., Sanzen, T. & Nakanuma, Y. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers. J Pathol 193, 210-217 (2001).
35. Wang, M. et al. Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice. J Leukoc Biol 96, 657-665 (2014).
36. Thakur, V., McMullen, M. R., Pritchard, M. T. & Nagy, L. E. Regulation of macrophage activation in alcoholic liver disease. J Gastroenterol Hepatol 22 Suppl 1, S53-56 (2007).
37. Lee, J., French, B., Morgan, T. & French, S. W. The liver is populated by a broad spectrum of markers for macrophages. In alcoholic hepatitis the macrophages are M1 and M2. Exp Mol Pathol 96, 118-125 (2014).
38. Saha, B., Bala, S., Hosseini, N., Kodys, K. & Szabo, G. Kruppel-like factor 4 is a transcriptional regulator of M1/M2 macrophage polarization in alcoholic liver disease. J Leukoc Biol 97, 963-973 (2015).
39. Martinez, P. & Blasco, M. A. Telomeric and extra-Telomeric roles for telomerase and the telomere-binding proteins. Nat Rev Cancer 11, 161-176 (2011).
40. Li, Y. & Tergaonkar, V. Noncanonical functions of telomerase: implications in telomerase-Targeted cancer therapies. Cancer Res 74, 1639-1644 (2014).
41. Tugal, D., Liao, X. & Jain, M. K. Transcriptional control of macrophage polarization. Arterioscler Thromb Vasc Biol 33, 1135-1144 (2013).
42. Mandrekar, P. & Szabo, G. Signalling pathways in alcohol-induced liver inflammation. J Hepatol 50, 1258-1266 (2009).
43. Tobias, P. S., Soldau, K. & Ulevitch, R. J. Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 264, 10867-10871 (1989).
44. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
45. Hayden, M. S. & Ghosh, S. NF-kappaB, the first quarter-century: remarkable progress and outstanding questions. Genes Dev 26, 203-234 (2012).
46. Bhatt, D. & Ghosh, S. Regulation of the NF-kappaB-Mediated Transcription of Inflammatory Genes. Front Immunol 5, 71 (2014).
47. Huang, W., Ghisletti, S., Perissi, V., Rosenfeld, M. G. & Glass, C. K. Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. Mol Cell 35, 48-57 (2009).
48. Baker, R. G., Hayden, M. S. & Ghosh, S. NF-kappaB, inflammation, and metabolic disease. Cell Metab 13, 11-22 (2011).
49. Perrault, S. D., Hornsby, P. J. & Betts, D. H. Global gene expression response to telomerase in bovine adrenocortical cells. Biochem Biophys Res Commun 335, 925-936 (2005).
50. Ghosh, A. et al. Telomerase directly regulates NF-kappaB-dependent transcription. Nat Cell Biol 14, 1270-1281 (2012).
51. Invernizzi, P. et al. Telomere dysfunction in peripheral blood mononuclear cells from patients with primary biliary cirrhosis. Dig Liver Dis 46, 363-368 (2014).
52. Wu, X. Q. et al. Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer. Cell Signal 25, 2462-2468 (2013).
53. Ruffell, B., Affara, N. I. & Coussens, L. M. Differential macrophage programming in the tumor microenvironment. Trends Immunol 33, 119-126 (2012).
54. Hoffmeyer, K. et al. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 336, 1549-1554 (2012).
55. Liao, X. et al. Kruppel-like factor 4 regulates macrophage polarization. J Clin Invest 121, 2736-2749 (2011).
56. Bertola, A., Mathews, S., Ki, S. H., Wang, H. & Gao, B. Mouse model of chronic and binge ethanol feeding (the NIAAA model). Nat Protoc 8 627-637 (2013).
57. Smedsrod, B. & Pertoft, H. Preparation of pure hepatocytes and reticuloendothelial cells in high yield from a single rat liver by means of Percoll centrifugation and selective adherence. J Leukoc Biol 38, 213-230 (1985).
58. Hansen, B., Arteta, B. & Smedsrod, B. The physiological scavenger receptor function of hepatic sinusoidal endothelial and Kupffer cells is independent of scavenger receptor class A type I and II. Mol Cell Biochem 240, 1-8 (2002).